Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?

Christophe Mannaerts (Corresponding author), Marc Engelbrecht, Arnoud Postema, Olivia Lodeizen, Rob van Kollenburg, Ruud van Sloun, Rogier Wildeboer, Massimo Mischi, Theo de Reijke, Hessel Wijkstra

Research output: Contribution to journalConference articleAcademicpeer-review

Abstract

Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

Fingerprint

Prostatic Neoplasms
Biopsy
Magnetic Resonance Imaging

Cite this

Mannaerts, Christophe ; Engelbrecht, Marc ; Postema, Arnoud ; Lodeizen, Olivia ; van Kollenburg, Rob ; van Sloun, Ruud ; Wildeboer, Rogier ; Mischi, Massimo ; de Reijke, Theo ; Wijkstra, Hessel. / Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?. In: Journal of Urology. 2019 ; Vol. 201, No. 4S. pp. e430-e430
@article{dc9e0e03b7a4451bbcb6918552e7ca87,
title = "Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?",
abstract = "Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.",
author = "Christophe Mannaerts and Marc Engelbrecht and Arnoud Postema and Olivia Lodeizen and {van Kollenburg}, Rob and {van Sloun}, Ruud and Rogier Wildeboer and Massimo Mischi and {de Reijke}, Theo and Hessel Wijkstra",
year = "2019",
month = "4",
day = "1",
doi = "10.1097/01.JU.0000557571.17930.bb",
language = "English",
volume = "201",
pages = "e430--e430",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "AUA Elsevier (Legacy Content)",
number = "4S",

}

Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy? / Mannaerts, Christophe (Corresponding author); Engelbrecht, Marc; Postema, Arnoud; Lodeizen, Olivia; van Kollenburg, Rob; van Sloun, Ruud; Wildeboer, Rogier; Mischi, Massimo; de Reijke, Theo; Wijkstra, Hessel.

In: Journal of Urology, Vol. 201, No. 4S, 01.04.2019, p. e430-e430.

Research output: Contribution to journalConference articleAcademicpeer-review

TY - JOUR

T1 - Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?

AU - Mannaerts,Christophe

AU - Engelbrecht,Marc

AU - Postema,Arnoud

AU - Lodeizen,Olivia

AU - van Kollenburg,Rob

AU - van Sloun,Ruud

AU - Wildeboer,Rogier

AU - Mischi,Massimo

AU - de Reijke,Theo

AU - Wijkstra,Hessel

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

AB - Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

U2 - 10.1097/01.JU.0000557571.17930.bb

DO - 10.1097/01.JU.0000557571.17930.bb

M3 - Conference article

VL - 201

SP - e430-e430

JO - Journal of Urology

T2 - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4S

ER -